A detailed history of Cfs Investment Advisory Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Cfs Investment Advisory Services, LLC holds 2,411 shares of NVS stock, worth $234,204. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,411
Previous 2,107 14.43%
Holding current value
$234,204
Previous $224,000 23.66%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$106.13 - $120.89 $32,263 - $36,750
304 Added 14.43%
2,411 $277,000
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $2,036 - $2,362
-22 Reduced 1.03%
2,107 $224,000
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $2,381 - $2,711
-25 Reduced 1.16%
2,129 $206,000
Q4 2023

Feb 13, 2024

BUY
$92.27 - $101.54 $8,119 - $8,935
88 Added 4.26%
2,154 $217,000
Q3 2023

Nov 14, 2023

BUY
$94.73 - $105.13 $195,712 - $217,198
2,066 New
2,066 $210,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cfs Investment Advisory Services, LLC Portfolio

Follow Cfs Investment Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfs Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfs Investment Advisory Services, LLC with notifications on news.